Document Detail


PD-1 inhibits T cell proliferation by upregulating p27 and p15 and suppressing Cdc25A.
MedLine Citation:
PMID:  23032366     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The programmed cell death-1 (PD)-1 receptor (CD279) is a potent T cell inhibitor with a critical role in peripheral tolerance, but it can also compromise anti-viral and antitumor T cell responses. The effects of PD-1 on the cell cycle leading to inhibition of T cell expansion are poorly understood. Recently, we examined the effects of PD-1 on the molecular control of the cell cycle machinery and on TCR-activated signaling pathways that regulate these downstream outcomes. Our studies showed that PD-1 blocks cell cycle progression in the G 1 phase. PD-1 did not alter the expression of G 1 phase cyclins or cyclin-dependent kinases (Cdks) but, instead, suppressed the transcription of SKP2, the substrate recognition component of the SCF (Skp2) ubiquitin ligase that leads p27 (kip1) to degradation and resulted in accumulation of p27 (kip1) . Subsequently, T cells receiving PD-1 signals displayed impaired Cdk2 activation and failed to phosphorylate two critical Cdk2 substrates, the retinoblastoma gene product (Rb) and the TGFβ-specific transcription factor Smad3, leading to suppression of E2F target genes but enhanced Smad3 transactivation. These events resulted in upregulation of the Cdk4/6 inhibitor p15 (INK4B) and repression of the Cdk-activating phosphatase Cdc25A. The suppressive effect of PD-1 on Skp2 expression was mediated by inhibition of both PI3K/Akt and Ras/MEK/Erk pathways and was only partially reversed by IL-2, which restored activation of MEK/Erk but not Akt. Thus, PD-1 targets Ras and PI3K/Akt signaling to inhibit transcription of Skp2 and to activate Smad3 as an integral component of a pathway that regulates blockade of cell cycle progression in T lymphocytes. Here, we discuss the detailed sequence of these signaling events and their implications in mediating cell-intrinsic and -extrinsic mechanisms that inhibit proliferation of T effector cells in response to PD-1-mediated signaling.
Authors:
Nikolaos Patsoukis; Duygu Sari; Vassiliki A Boussiotis
Related Documents :
22328166 - Formononetin-induced apoptosis of human prostate cancer cells through erk1/2 mitogen-ac...
23755096 - Prolactin-induced protein (pip) regulates proliferation of luminal a type breast cancer...
15316926 - Mitogen-activated protein kinases and asthma.
23064226 - Serine is a natural ligand and allosteric activator of pyruvate kinase m2.
21320696 - A receptor-like cytoplasmic kinase phosphorylates the host target rin4, leading to the ...
23279876 - Hyperglycemia is associated with enhanced gluconeogenesis in a rat model of permanent c...
Publication Detail:
Type:  Journal Article     Date:  2012-10-03
Journal Detail:
Title:  Cell cycle (Georgetown, Tex.)     Volume:  11     ISSN:  1551-4005     ISO Abbreviation:  Cell Cycle     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-10     Completed Date:  2013-05-17     Revised Date:  2013-12-04    
Medline Journal Info:
Nlm Unique ID:  101137841     Medline TA:  Cell Cycle     Country:  United States    
Other Details:
Languages:  eng     Pagination:  4305-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cell Proliferation
Cells, Cultured
Cyclin-Dependent Kinase 2 / metabolism
Cyclin-Dependent Kinase Inhibitor p15 / metabolism*
Cyclin-Dependent Kinase Inhibitor p27 / metabolism*
G1 Phase Cell Cycle Checkpoints
Humans
Interleukin-2 / metabolism
Phosphatidylinositol 3-Kinases / metabolism
Phosphorylation
Programmed Cell Death 1 Receptor / metabolism*
Proto-Oncogene Proteins c-akt / metabolism
Retinoblastoma Protein / metabolism
S-Phase Kinase-Associated Proteins / metabolism
Signal Transduction
Smad3 Protein / metabolism
T-Lymphocytes / cytology*,  immunology,  metabolism
Transcriptional Activation
Ubiquitin / metabolism
Up-Regulation
cdc25 Phosphatases / metabolism*
Chemical
Reg. No./Substance:
0/Cyclin-Dependent Kinase Inhibitor p15; 0/Interleukin-2; 0/Programmed Cell Death 1 Receptor; 0/Retinoblastoma Protein; 0/S-Phase Kinase-Associated Proteins; 0/Smad3 Protein; 0/Ubiquitin; 147604-94-2/Cyclin-Dependent Kinase Inhibitor p27; EC 2.7.1.-/Phosphatidylinositol 3-Kinases; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.11.22/Cyclin-Dependent Kinase 2; EC 3.1.3.48/cdc25 Phosphatases
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Scheduling of anticancer drugs: timing may be everything.
Next Document:  Developmental pathways in colon cancer: crosstalk between WNT, BMP, Hedgehog and Notch.